Toxic dermatitis in patients treated with Taxotere® (docetaxel) : three case reports
van Oijen, B.; Pleunis, M.; Erdkamp, F.; Prevoo, R.; van der Kuy, H.
International Journal of Clinical Pharmacology and Therapeutics 49(1): 46-48
2011
ISSN/ISBN: 0946-1965 PMID: 21176725 Document Number: 648227
Three out of 25 patients receiving the same batch docetaxel, developed toxic dermatitis within 5 days after administration. Timing of occurrence was equal and symptoms were similar. Two patients continued with docetaxel without any problems. There is no assignable cause found that could explain the toxic dermatitis.
Document emailed within 1 workday
Related Documents
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504Burris, H.A. 2000: Docetaxel (Taxotere) in the treatment of cancer Seminars in Oncology 27(2 Suppl 3: 1-2
Bruno, R.; Sanderink, G.J. 1993: Pharmacokinetics and metabolism of Taxotere (docetaxel) Cancer Surveys 17: 305-313
Hortobagyi, G.N. 1999: Recent progress in the clinical development of docetaxel (Taxotere) Seminars in Oncology 26(3 Suppl. 9): 32-36
Burris, H.A. 1999: Single-agent docetaxel (Taxotere) in randomized phase III trials Seminars in Oncology 26(3 Suppl 9): 1-6
Miller, V. 1999: Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer Seminars in Oncology 26(3 Suppl 10: 12-14
Distelmans, W.; Storme, G. 1999: The effect of pretreatment with docetaxel (taxotere; RP 56976) on irradiated subcutaneous MA 16/C murine tumors Journal of Experimental and Clinical Cancer Research: Cr 18(2): 167-172
Chen, M.; Crowson, A.Neil.; Woofter, M.; Luca, M.Beth.; Magro, C.M. 2004: Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases Journal of Rheumatology 31(4): 818-820
Armand, J.P. 2000: Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27 Suppl. 2: 223-230
Lissoni, P.; Vaghi, M.; Ardizzoia, A.; Fumagalli, E.; Tancini, G.; Gardani, G.; Conti, A.; Maestroni, G.J. 2001: Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer Neuro Endocrinology Letters 22(1): 27-29
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Belani, C.P. 1999: Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments Seminars in Oncology 26(3 Suppl 10: 15-18
Sato, T.; Oshima, T.; Yamamoto, N.; Fukahori, M.; Makino, H.; Nagano, Y.; Fujii, S.; Rino, Y.; Masuda, M.; Imada, T.; Kunisaki, C. 2009: A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1541-1544
Iwakura, S.; Shimamoto, T.; Higashiguchi, T.; Nakase, T.; Shimada, K.; Kunimoto, H.; Aoki, Y. 2012: A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1251-1253
Okubo, A.; Hino, N.; Ikushima, Y.; Mori, R.; Amano, S.; Tsuyuguchi, M.; Sounaka, Y.; Wada, D.; Yamasaki, S.; Miyake, H.; Miyoshi, T.; Ikawa, K.; Ogata, Y.; Matsuoka, H.; Kawakita, N.; Mikami, C. 2010: Two elderly patients with advanced breast cancer successfully treated by tri-weekly docetaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 911-914
Kimura, Y.; Shiraishi, O.; Kawakami, H.; Ueda, H.; Okuno, T.; Hiraki, Y.; Kato, H.; Iwama, M.; Yasuda, A.; Shinkai, M.; Chikugo, T.; Imano, M.; Imamoto, H.; Nakagawa, K.; Yasuda, T. 2018: A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 1812-1814
Matsuya, H.; Kawasaki, H.; Shibata, S.; Miyamoto, K.; Sasaki, M.; Itoh, J.; Kijima, H. 2007: A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(10): 1643-1646
Nishino, T.; Yamamoto, Y.; Ikeda, M.; Morimoto, M.; Furukawa, T.; Goto, M.; Furukita, Y.; Takechi, H.; Seike, J.; Tangoku, A.; Fujiwara, H. 2013: Pathological complete response in a case of advanced esophageal cancer invading aorta treated by preoperative chemotherapy with docetaxel and cisplatin plus 5-FU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(5): 643-646
Hashimoto, K.; Nio, Y.; Koike, M.; Itakura, M.; Yano, S.; Higami, T. 2004: A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1391-1393
Noro, H.; Hirao, T.; Takaichi, S.; Son, C.; Iwamoto, K.; Kono, E.; Yasumasa, K.; Mizuno, H.; Morimoto, Y.; Hatanaka, N.; Yamasaki, Y. 2016: Pathological Complete Response in a Case of Advanced Esophageal Cancer with Widespread Lymph Node Metastases Treated Using Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-FU(DCF therapy) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2178-2180